🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Idiopathic pulmonary fibrosis (IPF) is the most common form of chronic idio...
Status
Completed
Location
Rennes University Hospital - Service de Pneumologie
Start Date
2014-10-22
Trial ID
NCT04016168
Treatments Being Tested
Observational prospective cohort study designed to assess the mechanisms of...
Status
Unknown
Location
St Bartholomews Hospital
Start Date
2022-05-18
Trial ID
NCT06048458
This is a phase II study of Bevacizumab plus Temodar and Tarceva in patient...
Status
Completed
Location
University of California San Francisco
Start Date
2007-09
Trial ID
NCT00525525
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of ustekinumab as mea...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-15
Trial ID
NCT02349061
Treatments Being Tested
This is an open-label, non-randomized, multicenter, Phase 1/2a study to eva...
Status
Terminated
Location
Rambam Medical Center
Start Date
2022-11-15
Trial ID
NCT05581719
Treatments Being Tested
The study is a Phase II, dose-ranging, multicenter, randomized, double-blin...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00866788
Treatments Being Tested
SBRT Combined with CAPEOX, Bevacizumab, and PD-1 Inhibitor in RAS-Mutant, M...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02
Trial ID
NCT06835179
Treatments Being Tested
This research is being done to study the effects of the combination of ipil...
Status
Active Not Recruiting
Location
Massachusetts General Hospital Cancer Center
Start Date
2020-10-05
Trial ID
NCT04575922
Treatments Being Tested
This is an open label, phase II study to evaluate the capacity of Rituximab...
Status
Completed
Location
AKH Linz
Start Date
2012-05
Trial ID
NCT01611259
Treatments Being Tested
This clinical trail intends to evaluate interventions based on the Inflixim...
Status
Unknown
Location
Multiple Locations
Start Date
2015-09
Trial ID
NCT02522169
Treatments Being Tested